Drug modification of a risk factor of thrombosis in patients with varicosis
Haas, S.; von Eckstädt, A.V.; Lill, G.; Weichenmeier, I.; Blümel, G.
Fortschritte der Medizin 100(30): 1418-1422
1982
ISSN/ISBN: 0015-8178 PMID: 7129300 Document Number: 185350
Document emailed within 1 workday
Related Documents
Herrmann, W.; Biermann, J.; Lindhofer, H.G.; Kostner, G. 1989: Modification of the atherogenic risk factor Lp(a) by supplementary fish oil administration in patients with moderate physical training Medizinische Klinik 84(9): 429-433Kamphuisen, P.W.; Eikenboom, H.C.; Rosendaal, F.R.; Bertina, R.M. 2001: High concentration of coagulation factor VIIi as a risk factor for thrombosis Nederlands Tijdschrift Voor Geneeskunde 145(46): 2213-2217
Martinelli, I.; Landi, G.; Merati, G.; Cella, R.; Tosetto, A.; Mannucci, P.M. 1996: Factor V gene mutation is a risk factor for cerebral venous thrombosis Thrombosis and Haemostasis 75(3): 393-394
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488
Sharma, S.K.; Gupta, V.; Kadhiravan, T.; Banga, A.; Seith, A.; Kumar, A.; Saxena, R.; Thabah, M.M.; Gulati, V.; Bhatia, I.; Kavimandan, A.A. 2009: A prospective study of risk factor profile and incidence of deep venous thrombosis among medically-ill hospitalized patients at a tertiary care hospital in northern India Indian Journal of Medical Research 130(6): 726-730
Fletcher, G.F. 1981: Exercise and coronary risk factor modification in the management of atherosclerosis Heart and Lung: the Journal of Critical Care 10(5): 811-813
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Juhan-Vague, I. 1989: Is hypofibrinolysis a risk factor of thrombosis? La Revue du Praticien 39(26): 2337-2339
Singh, R.B.; Rastogi, S.S.; Sircar, A.R.; Mehta, P.J.; Sharma, K.K. 1991: Dietary strategies for risk-factor modification to prevent cardiovascular diseases Nutrition 7(3): 210-214
Willems, H.P.; den Heijer, M.; Blom, H.J.; Gerrits, W.B.; Rosendaal, F.R.; Bos, G.M. 1999: Hyperhomocysteinemia as a risk factor for venous thrombosis Nederlands Tijdschrift Voor Geneeskunde 143(11): 552-556
Kołodziejczyk, J.; Wachowicz, B. 2009: Dysfunction of fibrinolysis as a risk factor of thrombosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 27(160): 341-345
Alessandrello Liotta, A.; Marcucci, R.; Bialek, W.; Poli, D.; Ilari, I.; Fedi, S.; Cellai, A.P.; Rogolino, A.; Prisco, D.; Abbate, R. 1999: Lp(a): a new risk factor for deep venous thrombosis? Minerva Cardioangiologica 47(12): 529
Louria, D.B.; Lavenhar, M.A.; Quinones, M.A.; Schneider, D.J.; Foster, J.D. 1977: Program for risk factor modification and selective screening for ostensibly healthy adults Journal of the Medical Society of New Jersey 74(9): 759-767
Colucciello, M. 2005: Retinal vascular disease in hypertension. Risk factor modification optimizes vision outcomes Postgraduate Medicine 117(6): 33-8 41-2
Shigekiyo, T.; Uno, Y.; Tomonari, A.; Satoh, K.; Hondo, H.; Ueda, S.; Saito, S. 1992: Type i congenital plasminogen deficiency is not a risk factor for thrombosis Thrombosis and Haemostasis 67(2): 189-192
Castaman, G.; Faioni, E.M.; Tosetto, A.; Bernardi, F. 2003: The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis Haematologica 88(10): 1182-1189
Schlosser, U.; Lackner, K.J.; Scheckenhofer, C.; Spannagl, M.; Spengel, F.A.; Hahn, G.; Lang, B.; Schmitz, G. 1997: Autoantibodies against the protease inhibitor calpastatin: a new risk factor for venous thrombosis? Thrombosis and Haemostasis 77(1): 11-13
Minnee, R.C.; Middeldorp, S.; Legemate, D.A. 2009: Malformation of the V. cava inferior, a risk factor for deep venous thrombosis Nederlands Tijdschrift Voor Geneeskunde 153(11): 496-500
Lane, D.M. 2001: Third report of the National Cholesterol Education Program (NCEP. III): A switch from dietary modification to risk factor assessment Current Opinion in Investigational Drugs 2(9): 1235-1236
Saadatnia, M.; Naghavi, N.; Fatehi, F.; Zare, M.; Tajmirriahi, M. 2012: Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 17(4): 344-347